Archives: Publications

Lower Case Mix Adjusters Are Associated With Lower Erythropoiesis-Stimulating Agent and Other Bundled Costs

Posted by:

Scott Sibbel, Jaime Rubin and Alex Yang. Lower case mix adjusters are associated with lower erythropoiesis-stimulating agent and other bundled costs. International Society for Pharmacoeconomics and Outcomes Research. Washington, DC,… Read more

Erythropoietin-stimulating agent (ESA) dose recovery following hospitalization OF end stage renal disease (ESRD) patients

Posted by:

Steven Wang, T. Christopher Bond, Jaime Rubin, Alex Yang. Erythropoietin-stimulating agent (ESA) dose recovery following hospitalization of end stage renal disease (ESRD) patients. International Society for Pharmacoeconomics and Outcomes Research…. Read more

Reduced Use Of Erythropoiesis-Stimulating Agents and Intravenous Iron with Ferric Citrate: A Medicare Bundle Cost-Offset Model

Posted by:

Mutell R, Rubin JL, Bond TC, Mayne T. Reduced use Of erythropoiesis-stimulating agents and intravenous iron with ferric citrate: A medicare bundle cost-offset model. International Society for Pharmacoeconomics and Outcomes… Read more

Pseudo-Randomization in Retrospective Analysis Using the Generalized Multinomial Logit for Propensity Score Generation

Posted by:

Wilson S, Mayne T. Pseudo-randomization in retrospective analysis using the generalized multinomial logit for propensity score generation. International Society for Pharmacoeconomics and Outcomes Research. Washington, DC, Jun 2-6, 2012. Read more

Perceptions and Roles of the Nephrology Social Worker Within the Suicide Continuum of Care: A National Survey

Posted by:

Kwatcher J, Mora A, Muhr JR, Stricherz M. Perceptions and roles of the nephrology social worker within the suicide continuum of care: A National Survey. National Kidney Foundation Spring Meeting…. Read more

Disease Management Program ESRD Patients Have Lower Overall Medical Costs

Posted by:

Franco E, Jhu E, Parks J, Nissenson AR, McMurray S. Disease management program ESRD patients have lower overall medical costs. National Kidney Foundation Spring Meeting. Washington, DC, May 9-13, 2012. Read more

More Frequent Hemoglobin (Hb) Measurements and Erythropoiesis-Stimulating Agent (ESA) Titrations Are not Associated with Increased Time in Target Hb Range

Posted by:

Bond TC, Rubin MA, Wang S, Yang A. More Frequent Hemoglobin (Hb) Measurements and erythropoiesis-stimulating agent (ESA) titrations are not associated with increased time in target Hb range. National Kidney… Read more

Crit-Line® Monitor Use in Incident Hemodialysis Patients Improves Dry Weight and Adequacy While Reducing Epoetin Alfa Dose: A Propensity Score Matched Study

Posted by:

Sibbel S, Ficociello LH, Black M, Thakuria M, Mullon C, Diaz-Buxo J, Alfieri T. Crit-Line Monitor use in incident hemodialysis patients improves dry weight and adequacy while reducing epoetin alfa… Read more

Hemoglobin Recovery Following Hospitalization in ESRD Patients

Posted by:

Bond TC, Rubin MA, Wang S, Yang A, Krishnan M. Hemoglobin recovery following hospitalization in ESRD patients. National Kidney Foundation Spring Meeting. Washington, DC, May 9-13, 2012. Read more

Video Education Increases Patient Knowledge About Phosphorus Control and is a Preferred Form of Education

Posted by:

Boyd S, Bond TC, Zimmerman T, Parker K, Griffin D, Dunn D. Video education increases patient knowledge about phosphorus control and is a preferred form of education. National Kidney Foundation… Read more